Fecal microbiota transplantation for recurrent Clostridioides difficile infection

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Stacy L HaberJennifer Park Lau

Abstract

Randomized controlled trials investigating the efficacy and safety of fecal microbiota transplantation (FMT) for recurrent Clostridioides difficile infection (CDI) are reviewed, and practical issues for pharmacists to consider are discussed. Eight randomized controlled trials evaluating the use of FMT for recurrent CDI were analyzed. The trials varied in the type of sample (fresh, frozen, lyophilized), route of administration (nasogastric tube, colonoscopy, enema, oral), and comparator agent (different type of FMT, vancomycin). Efficacy rates ranged from 43.8% to 96.2% with FMT, and safety data were relatively similar. With these favorable data, pharmacists are likely to be involved at multiple steps in the delivery of FMT to patients with recurrent CDI, including the procurement, documentation, and administration of various products and patient education. FMT is an option for recurrent CDI that is supported by findings of randomized controlled trials, although a preferred method for the delivery remains to be defined. Pharmacists can play an important role in the successful management of patients with recurrent CDI who may benefit from FMT.

References

Aug 19, 2010·Journal of Clinical Gastroenterology·Martin J GrehanAntony Wettstein
Jan 18, 2013·The New England Journal of Medicine·Els van NoodJosbert J Keller
Feb 14, 2015·Infectious Disease Clinics of North America·Jennie H KwonErik R Dubberke
Feb 26, 2015·The New England Journal of Medicine·Fernanda C LessaL Clifford McDonald
May 6, 2015·Annals of Internal Medicine·Dimitri DrekonjaTimothy J Wilt
May 26, 2016·MMW Fortschritte der Medizin·Bernhard RamsauerJan-Michel Otte
Dec 25, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Susy S HotaSusan M Poutanen
Mar 22, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L Clifford McDonaldMark H Wilcox
Jun 5, 2018·The New England Journal of Medicine·Frederik E JuulHans-Olov Adami

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.